source Post navigation First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 … – BMC Medicine Diabetes Devices Market Share is Expected to Climb 68.2 Billion by … – GlobeNewswire
